A solid clinical win for a promising candidate helped jolt the stock a few months ago. And just last week, the company’s latest quarterly update provided yet another boost. Here is why Eli Lilly is a …
This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy
view original post